Serum gastrin and gastrin-immunoreactive cells in the antral mucosa of patients with alcoholic liver disease

APMIS

Volumn 108, Issue 1, 2000, Pages 51-56

  Cortez Pinto, Helena ^a   Ferra, Maria Amélia ^c   Baptista, Amélia ^b   De Moura, Miguel Carneiro ^a   Portela Gomes, Guida Maria ^a,d  

^a Centre of Gastroentrology   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c Dept of Nucl Med Cancer I ^*  (Portugal)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alcoholic liver disease; Antrum; Gastrin cells; Human; Immunocytochemistry; Liver disease; Serum gastrin

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GASTRIN BLOOD LEVEL; GASTRIN CELL; GASTRIN RELEASE; HUMAN; HYPERGASTRINEMIA; IMMUNOCYTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; STOMACH ANTRUM;

EID: 0033950191     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-5.x     Document Type: Article

References (36)

1. 1. Rehfeld JF, Bardram L, Cantor P, Hilsted L, Schwartz TW. Cell specific processing of pro-cholecystokinin and pro-gastrin. Biochemie 1988;70: 25-31.
2. 2. Walsh JH, Lam SKL. Physiology and pathology of gastrin. Clin Gastroenterol 1980;9:567-91.
3. 3. Lam SK. Hypergastrinaemia in cirrhosis of the liver. Gut 1976;17:700-8.
4. 4. Lauritsen KB, Rehfeld JF, Christiansen LA, Juhl E, Stadil F. Serum gastrin in cirrhosis. Scand J Gastroent Suppl 1976;37:33-4.
5. 5. Mazzaca G, Budillon G, De Marco F, De Ritis F. Serum gastrin in patients with cirrhosis of the liver. Digestion 1980;11:232-9.
6. 6. Sato T, Imamura M, Sasaki I, Ohneda A. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients. Am J Gastroenterol 1985;80:163-9.
7. 7. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni ML, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
8. 8. Rehfeld JF. The influence of antiserum properties on radioimmunoassay characteristics. In: Thorell JI, editor. Radioimmunoassay Design and Quality Control. Paris: Pergamon Press; 1982, 19-27.
9. 9. Thorell JI, Larson SM. Receptors for radioligand assay. In: Radioimmunoassay and Related Techniques. St. Louis: The CV Mosby Company; 1978, 11-31.
10. 10. Ekins R. The precision profile: its use in RIA. Assessment and design. Ligand Quarterly 1981; 4:33-44.
11. 11. Hsu SM, Raine T, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
12. 12. Sternberger LA. Immunochemistry. 3rd ed. New York: John Wiley; 1986.
13. 13. Floderus S. Untersuchungen über den Bau der menschlichen Hypophyse besonderer Berücksichtiung der quantitativen mikromorphologischen Verhältnisse. Acta Path Microbiol Scand 1944; Suppl 53: 1-276.
14. 14. Portela-Gomes GM, Grimelius L, Petersson R, Bergström R. Enterochromaffin cells in the rat gastrointestinal tract. Aspects of factors influencing quantification. Uppsala J Med Sci 1984; 89:189-203.
15. 15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20:1161-81.
16. 16. Pointner H. Normal serum gastrin levels in patients with liver cirrhosis. Digestion 1975;13:372-4.
17. 17. Tarquini B, Anichini P, Brocchi A, Falchi S, Tommasi S. Chronobiological study on serum immunoreactive gastrin RIA levels in patients with liver cirrhosis. Digestion 1977;15:447-51.
18. 18. Singer MW, Leffmann C, Eysselein VE, Calden H, Goebell H. Action of ethanol and some alcoholic beverages on gastric acid secretion and release of gastrin in humans. Gastroenterology 1987;93:1247-54.
19. 19. Treffot MJ, Laugier R, Bretholz A, Voirol M, Sarles H. Increased gastrin release in chronic calcifying pancreatitis and in chronic alcoholism. Horm Metab Res 1980;12:240-2.
20. 20. Peterson WL, Barnett C, Walsh JH. Effect of intragastric infusion of ethanol and wine on serum gastrin concentration and gastric acid secretion. Gastroenterology 1986;91:1390-5.
21. 21. Quintero E, Pique JM, Bombi JA, Bordas JM, Sentes J, Elena M, et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinaemia and low serum levels of pepsinogen I. Gastroenterology 1987;93:1054-61.
22. 22. Graham DY, Go MF, Lew GM, Genta RM, Rehfeld JF. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol 1993;28:690-4.
23. 23. Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 1994;35:615-8.
24. 24. Balan KK, Jones AT, Roberts NB, Pearson JP, Critchley M, Jenkins SA. The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 1996;91:1400-6.
25. 25. Schmulson MJ, De Leon G, Kershenovich A, Vargas-Vorackova F, Kershenobich D. Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis. Helicobacter 1977;2:149-51.
26. 26. Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, et al. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopie features and the risk of peptic ulcer. Dig Dis Sci 1997;2024-30.
27. 27. Royston CMS, Polak J, Bloom SR, Cooke WM, Russel RCG, Pearse AGE, et al. G cell population of gastric antrum, plasma gastrin, and gastric acid secretion in patients with and without duodenal ulcer. Gut 1978;19:689-98.
28. 28. Pinto HC, Portela-Gomes GM, Grimelius L, Kohnert KD, de Sousa JC, Albuquerque MAP. The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology 1995;108:967-74.
29. 29. Hellman B, Hellerström C. Diurnal changes in the function of the pancreatic islets of rats indicated by nuclear size in the islets cells. Acta Endocrinol 1959;31:267-81.
30. 30. Hulquist GT. An empirical study to ascertain the value of measurement of nuclear size and eccentricity in assessing functional changes in the cells of Langerhans islets. Acta Anat 1965;60:193-8.
31. 31. Hara M, Varndell I, Bishop AE, Aitchison M, Rode J, Yamada T, et al. Expression of the C-terminal flanking peptide of human progastrin in human gastrointestinal mucosa, G-cell hyperplasia and islet cell tumours producing gastrin. Mol Cell Probes 1987;1:95-108.
32. 32. Hattori N, Kurachi H, Ikekubo K, Ishihara T, Moridera K, Hino M, et al. Serum growth hormone-binding protein, insulin-like growth factor-I and growth hormone in patients with liver cirrhosis. Metabolism 1992;41:377-81.
33. 33. Lin HC, Yang MC, Hou MC, Lee FY, Huang YT, Lin LF, et al. Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values. J Gastroenterol Hepatol 1996;11:422-8.
34. 34. Henriksen JH, Staun-Olsen P, Fahrenkrug J, Ring-Larsen H. Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds. Scand J Gastroentrol 1980;15:787-92.
35. 35. Paloheimo L, Clemmesen O, Dalhoff K, Rehfeld JF. Plasma cholecystokinin and its precursors in hepatic cirrhosis. J Hepatol 1997;27:299-305.
36. 36. Beaudry P, Hadengue A, Callarbert J, Gaudin C, Solimon H, Moreau R, et al. Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology 1994;20:800-3.